Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Paul Taylor tells us about his Precision-Panc experience Precision-Panc help raise funds for Pancreatic Cancer Scotland Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Home | Patients and Carers | Patient Stories

Maggie Shapland had retired in 2013 after a 40-year career as a database consultant and developer at the University of Bristol Computer Centre and continued to be busy with volunteer work on heritage projects. It came as a complete shock when she was diagnosed in October 2016 with Stage 4 metastatic pancreatic cancer at the age of 70.

I was very fit and my health had always been very good,’ said Maggie. ‘All I had was heartburn, there was no weight loss. No one could believe I could look and feel so well with metastatic cancer and had only been given a few months to live‘.

My partner of 14 years was devastated, but fortunately we have many friends he was able to turn to for comfort. We were married soon after the diagnosis in December 2016, in a joyous, if unconventional event. My sons were clearly upset, but supportive, as were my brother and sister. I was determined to keep strong for everyone, and to keep on with my heritage projects and drive my vintage cars as much as possible, to show to people that I am still enjoying life‘.

Due to the fact that I was physically fit enough to withstand the side effects, I was offered FOLFIRINOX rather than GemCap, as there was a chance I would live longer. The chemo course was between November 2016 and May 2017, although the dosage had to be reduced several times due to side effects and the cumulative effect was more than I expected.’

Maggie’s book The ups and downs of the Clifton Rocks Railway and the Clifton Spa was published in December 2017, but around this time her blood tests started to show some worrying signs and Maggie began to lose weight.

A CT scan in March 2018 showed that although the pancreatic tumour was still stable, the liver metastases were growing and there were new tumours on the lymph nodes. I started a six-month course of GemCap on 30 April 2018. I was now also diabetic (type 3) – a side effect of the cancer. However, I needed to gain weight to keep my strength up, so take metformin with every meal, as well as insulin on treatment days as the steroids send my glucose levels very high. I am also on blood thinners for the rest of my life as a result of having two blood clots – another side effect‘. 

After three months the metastases on my lymph nodes had vanished, the liver metastases were disappearing and the pancreatic tumour had shrunk by half. By December 2018, after six months of treatment, my condition was stable.’

Although Maggie is not as physically fit as she was, she has organised successful open days for the Clifton Rocks Railway, and is working on the Brunel Swivel bridge and a new book on the Nailsea coalfields. She is also maintaining her passion for vintage cars and is booked to give talks as far ahead as September 2019.

‘I am determined to live life to the full, although I do get a bit tired sometimes.’

‘I am really glad there are finally Precision-Panc trials open in Bristol, since all too often they are too far away and at only one site. I am glad there are no placebos in Precision-Panc and it will be fantastic if I can get on these trials when my situation changes.’

It was a great shock to John Currie’s family when he was diagnosed with pancreatic cancer in November 2015 at 62. His daughter Janice shares his story.

‘Dad had what would be classed as a really good healthy lifestyle,’ said Janice. ‘He regularly cycled and was very fit and healthy. He had ongoing thyroid problems, but these were well controlled.’

‘In October 2015, Dad began to get tired and thought a holiday would help. The following week he became jaundiced, was admitted to hospital through A&E and diagnosed with inoperable pancreatic cancer.’

‘The prognosis was three to six months and Dad had eight months, almost to the day. An excellent team of district nurses provided support and at the end, Marie Curie nurses helped us with overnight stays, for which we were extremely grateful.’

‘Initially, Dad had a stent fitted to ease the jaundice and went on to have a drain inserted to help with fluid collection. This allowed Dad to be at home, which was very important to him. He chose not to accept palliative chemotherapy, which we respected.’

‘During the eight months, Dad did have some good times. He even managed a small cycle and saw family and friends and his pain was really well controlled throughout. At the beginning, changes in his condition were visible monthly, then weekly, and finally, daily.’

‘It was really difficult as a family. It came as a total shock, but as time progressed, the reality began to settle in. Dad’s attitude, faith and approach to the diagnosis was without a doubt very helpful and he tried to make things as easy for us as possible. Time became very important – time to accept, say goodbye and move forward, which Dad was very keen for us to do.’

‘It is a real privilege to be involved in some part in Precision-Panc’s vitally important research as it begins to offer hope and a future for people who are diagnosed with pancreatic cancer. I am incredibly proud of the people who have registered to participate in Precision-Panc clinical trials and of the talented researchers and medics who are determined to take on pancreatic cancer.’

© 2020 Precision Panc
Web design by Creatomatic
This site uses cookies.
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.